Transcutaneous electrical nerve stimulation reduces movement‐evoked pain and fatigue: a randomized, controlled trial
Arthritis & Rheumatology Mar 25, 2020
Dailey DL, Vance CGT, Rakel BA, et al. - This research was carried out to assess applying transcutaneous electrical nerve stimulation (TENS) during activity would enhance movement‐evoked pain and other patient‐reported outcomes in women with fibromyalgia (FM). Individuals were allocated randomly to receive active TENS (n = 103), placebo TENS (n = 99), or no TENS (n = 99) and instructed to use it at home during activity 2 hours each day for 4 weeks. The primary endpoint measure and secondary patient‐reported endpoints were evaluated at baseline (time of randomization) and at 4 weeks. The evidence showed that a greater reduction in movement‐evoked pain was recorded in the active TENS group vs the placebo TENS group and vs the no TENS group. The study found that four weeks of active TENS use compared with placebo TENS or no TENS resulted in a significant improvement in movement‐evoked pain and other clinical outcomes among women who had FM and were on a stable medication regimen. Future research is required to analyze effectiveness in a real‐world setting to establish the clinical importance of these findings.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries